Pharmacytimes: Condition Center: Diabetes http://www.pharmacytimes.com/condition-resources/diabetes/condition-rss Diabetes en-us Thu, 14 Dec 2017 02:52:55 UTC Thu, 14 Dec 2017 02:52:55 UTC Reducing Cardiovascular Risk in Patients with Type 2 Diabetes and established CVD using Evidence-Based Medicine http://www.pharmacytimes.com/publications/issue/2017/November2017/R891_November2017 5:36 PM, Mon December 11, 2017 ADA Releases 2018 Standards of Care for Diabetes http://www.pharmacytimes.com/resource-centers/diabetes/ada-releases-2018-standards-of-care-for-diabetes The American Diabetes Association (ADA) has released their annual <em>Standards of Medical Care in Diabetes </em>for 2018, highlighting several updated recommendations for diabetes care and management.<br /> &nbsp; 1:07 PM, Mon December 11, 2017 FDA Approves Once-Weekly Semaglutide for Type 2 Diabetes http://www.pharmacytimes.com/product-news/fda-approves-onceweekly-semaglutide-for-type-2-diabetes The FDA has approved Novo Nordisk&rsquo;s semaglutide injection (Ozempic), a glucagon-like peptide 1 (GLP-1) receptor agonist, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.&nbsp; 2:06 PM, Tue December 5, 2017 Medication Management in Schools: Pharmacist Involvement Can Improve Outcomes http://www.pharmacytimes.com/resource-centers/asthma/medication-management-in-schools-pharmacist-involvement-can-improve-outcomes Between 10% and 20% of students in kindergarten through high school have chronic illness. 8:00 AM, Tue December 5, 2017 Longtime Pharmacy Educator Honored with Prestigious Award http://www.pharmacytimes.com/resource-centers/diabetes/longtime-pharmacy-educator-honored-with-prestigious-award It&rsquo;s been more than 6 decades since Professor R. Keith Campbell, from Washington State University, was diagnosed with diabetes.<br /> &nbsp; 10:28 AM, Tue November 28, 2017 Insulin Dosing Apps Are on Their Way http://www.pharmacytimes.com/contributor/timothy-aungst-pharmd/2017/11/insulin-dosing-apps-are-coming-and-patients-will-use-them What do pharmacists need to know about these mobile applications recently approved by the FDA? 8:00 AM, Tue November 21, 2017 Pharmacists Play a Key Role in Diabetes Management http://www.pharmacytimes.com/contributor/marilyn-bulloch-pharmd-bcps/2017/11/pharmacists-play-a-key-role-in-diabetes-management November is diabetes awareness month, and pharmacists are excellent resources for patients who have this chronic condition. 11:52 PM, Mon November 20, 2017 Empowering Patients to Take Charge of Their Health http://www.pharmacytimes.com/contributor/christina-tarantola/2017/11/empowering-patients-to-take-charge-of-their-health When pharmacists promote behavioral changes, it encourages positive patterns that last a lifetime. 10:55 PM, Mon November 13, 2017 Dapagliflozin/Saxagliptin to Treat Inadequately Controlled Type 2 Diabetes http://www.pharmacytimes.com/contributor/aakash-gandhi-pharmd-candidate-2017/2017/11/dapagliflozin-saxagliptin-to-treat-inadequately-controlled-type-2-diabetes Does this antihyperglycemic combination medication need to be added to a formulary? 4:05 PM, Mon November 13, 2017 Type 2 Diabetes and Inflammation: What's the Connection? http://www.pharmacytimes.com/resource-centers/diabetes/type-2-diabetes-and-inflammation-whats-the-connection A growing body of data show&nbsp;that type 2 diabetes is at least in part rooted in inflammation, said Edgar Engleman, MD, a professor of pathology and medicine at Stanford University. 9:35 AM, Sun November 12, 2017 CANVAS Trial: Canagliflozin Linked with Improved Renal Outcomes http://www.pharmacytimes.com/resource-centers/diabetes/canvas-trial-canagliflozin-linked-with-improved-renal-outcomes Canagliflozin (Invokana, Janssen) improved renal outcomes and demonstrated potential renal protective effects, according to additional analyses from the CANVAS clinical trial presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting. 1:10 PM, Tue November 7, 2017 Long-Acting Insulins Useful Tools in Type 1 and Type 2 Diabetes http://www.pharmacytimes.com/publications/issue/2017/October2017/longacting-insulins-useful-tools-in-type-1-and-type-2-diabetes Researchers have augmented insulin&rsquo;s effectiveness with several rapid and long-acting analogs and new delivery systems, such as insulin pens and insulin pumps. 1:30 PM, Wed October 25, 2017 Self-Monitoring of Blood Glucose: An Essential Weapon in Managing Diabetes http://www.pharmacytimes.com/publications/issue/2017/October2017/selfmonitoring-of-blood-glucose-an-essential-weapon-in-managing-diabetes The number of diabetes cases continues to soar, with the latest data showing that an estimated 30.3 million Americans have the disease. 1:00 PM, Wed October 25, 2017 Star Players on the Diabetes Care Team http://www.pharmacytimes.com/publications/issue/2017/October2017/star-players-on-the-diabetes-care-team The increasing incidence of diabetes is outpacing the number of health care providers skilled in caring for affected patients. 12:00 PM, Wed October 25, 2017 Semaglutide Gets FDA Advisory Committee Backing http://www.pharmacytimes.com/news/semaglutide-gets-fda-advisory-committee-backing Officials with Novo Nordisk have announced that the FDA&#39;s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 16-0, supporting the approval of once-weekly semaglutide to improve glycemic control in adults with type 2 diabetes. 10:53 PM, Wed October 18, 2017 New Drugs Introduced in 2017: Part 2 Endocrinology and Gastroenterology http://www.pharmacytimes.com/contributor/marilyn-bulloch-pharmd-bcps/2017/10/new-drugs-introduced-in-2017-part-2-endocrinology-and-gastroenterology This year, the FDA is on pace to approve about 38 new medications. Here is a look at 5 of those. 10:26 PM, Tue October 17, 2017 Lowering Cardiovascular Disease Risk for Patients With Diabetes http://www.pharmacytimes.com/publications/issue/2017/DiabetesSupplementSeptember2017/lowering-cardiovascular-disease-risk-for-patients-with-diabetes- Although there are many ways a patient can reduce the risk for diabetes or complications from diabetes, pharmacists have intimate knowledge of a patient 1:47 PM, Fri October 13, 2017 Managing the Cost of Diabetes http://www.pharmacytimes.com/publications/issue/2017/DiabetesSupplementSeptember2017/managing-the-cost-of-diabetes- 12:02 PM, Fri October 13, 2017 Diabetic Foot Care http://www.pharmacytimes.com/publications/issue/2017/DiabetesSupplementSeptember2017/diabetic-foot-care- Patient education and understanding the relationship between hyperglycemia, peripheral vascular disease, neuropathy, and foot complications are essential to reduce the potential for foot injury, ulceration, or amputation. 11:12 AM, Fri October 13, 2017 Driving Patient Adherence (and Outcomes) Through Appointment-Based Refill Programs http://www.pharmacytimes.com/publications/issue/2017/DiabetesSupplementSeptember2017/driving-patient-adherence-and-outcomes-through-appointmentbased-refill-programs One of the biggest struggles facing patients today is ensuring they have the proper medications on hand and that they are taking their medications correctly. 6:00 PM, Thu October 12, 2017